Cambridge, MA, United States of America

Aaron Baskerville-Bridges

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aaron Baskerville-Bridges. Retrieved from https://idiyas.com/inventor/aaron-baskerville-bridges

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Aaron Baskerville-Bridges

Introduction

Aaron Baskerville-Bridges is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biopharmaceutical production. His innovative work focuses on data-driven predictive modeling, which enhances the selection of cell lines for production processes.

Latest Patents

Aaron holds a patent for "DATA-DRIVEN PREDICTIVE MODELING FOR CELL LINE SELECTION IN BIOPHARMACEUTICAL PRODUCTION." This patent represents a crucial advancement in optimizing biopharmaceutical manufacturing, showcasing his expertise and commitment to innovation. He has 1 patent to his name.

Career Highlights

Aaron is currently employed at Amgen Inc., a leading biotechnology company. His role at Amgen allows him to apply his innovative ideas in a practical setting, contributing to the development of new therapies and solutions in the biopharmaceutical industry.

Collaborations

Aaron has collaborated with talented coworkers, including Yucen Xie and Jennitte LeAnn Stevens. These partnerships have fostered a creative environment that encourages the exchange of ideas and enhances the overall impact of their work.

Conclusion

Aaron Baskerville-Bridges exemplifies the spirit of innovation in the biopharmaceutical sector. His contributions through patenting and collaboration highlight the importance of data-driven approaches in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…